author-photo

Michael Thorsgaard

Aarhus University Hospital

8

Papers

31

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Patients with Primary Central Nervous System Lymphoma Have High Levels of Soluble Programmed Cell Death Protein 1 in Their Pretherapeutic Cerebrospinal Fluid

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
CLINICAL IMPACT OF T-CELL RECEPTOR REPERTOIRE DIVERSITY IN PATIENTS WITH LYMPHOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION

2021 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Level of Unique T-Cell Clonotypes Are Associated with Clonal Hematopoiesis and Survival in Patients with Lymphoma Intended for Autologous Stem Cell Transplant

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
HIGH RISK OF ADVERSE EVENTS AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION IN LYMPHOMA PATIENTS WITH DNA REPAIR PATHWAY MUTATIONS: A NATION-WIDE COHORT STUDY

2019 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Clinical Impact of Clonal Hematopoiesis after Autologous Stem Cell Transplantation for Lymphoma: A National Population-Based Study

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)
The Combination of Pixantrone, Etoposide, Bendamustine and, in CD20+ Tumors, Rituximab (PREBEN) Shows Promising Feasibility/Efficacy in Heavily Pre-Treated Aggressive Lymphomas of B- and T-Cell Phenotype - Results of the Pre-Trial Experience Leading to a Nordic Phase 1/2 Study (the PREBEN Trial)

2016 Blood
Show All
- Source
- Cite
- Save
Citations (9)
Preliminary Clinical Experience on the Efficacy and Feasibility of a New Combination Regimen Consisting of Pixantrone, Etoposide, and Bendamustine with or without the Addition of Rituximab in Patients with Relapsed/Refractory Aggressive Non-Hodgkin Lymphomas

2014 Blood
Show All
- Source
- Cite
- Save
Citations (5)